Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Common Equity: 2020-2025

Historic Common Equity for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to $3.1 million.

  • iSpecimen's Common Equity fell 34.83% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 34.83%. This contributed to the annual value of $3.3 million for FY2024, which is 66.01% down from last year.
  • iSpecimen's Common Equity amounted to $3.1 million in Q3 2025, which was up 394.03% from $621,973 recorded in Q2 2025.
  • iSpecimen's Common Equity's 5-year high stood at $29.8 million during Q4 2021, with a 5-year trough of $621,973 in Q2 2025.
  • Its 3-year average for Common Equity is $7.4 million, with a median of $6.1 million in 2024.
  • As far as peak fluctuations go, iSpecimen's Common Equity soared by 209.21% in 2021, and later slumped by 89.79% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Common Equity stood at $29.8 million in 2021, then slumped by 31.83% to $20.3 million in 2022, then crashed by 52.04% to $9.7 million in 2023, then crashed by 66.01% to $3.3 million in 2024, then crashed by 34.83% to $3.1 million in 2025.
  • Its Common Equity was $3.1 million in Q3 2025, compared to $621,973 in Q2 2025 and $1.7 million in Q1 2025.